Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.96 USD | +0.20% | +8.77% | +16.16% |
Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
Business Summary
Number of employees: 274
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Treatments for Cancer
100.0
%
| 91 | 100.0 % | 100 | 100.0 % | +9.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 91 | 100.0 % | 100 | 100.0 % | +9.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Nick Leschly
CHM | Chairman | 51 | 21-05-03 |
Susan Abu-Absi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 22-02-13 | |
Jenn Snyder
IRO | Public Communications Contact | - | - |
Investor Relations Contact | - | - | |
Teresa Jurgensen
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Lynch
BRD | Director/Board Member | 65 | 21-10-14 |
Nick Leschly
CHM | Chairman | 51 | 21-05-03 |
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Denice Torres
BRD | Director/Board Member | 64 | 21-10-14 |
Sarah Glickman
BRD | Director/Board Member | 54 | 21-10-14 |
Wei Lin
BRD | Director/Board Member | 63 | 23-03-06 |
Marcela Maus
BRD | Director/Board Member | 48 | 21-10-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,404,837 | 50,120,123 ( 97.50 %) | 0 | 97.50 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.16% | 254M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- TSVT Stock
- Company 2seventy bio, Inc.